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Abstract
Although previous studies have highlighted associations of cannabis use with cognition
and brain morphometry, critical questions remain with regard to the association between
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cannabis use and brain structural and functional connectivity. In a cross-sectional commu-
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nity sample of 205 African Americans (age 18–70) we tested for associations of cannabis
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use disorder (CUD, n = 57) with multi-domain cognitive measures and structural, diffusion, and resting state brain-imaging phenotypes. Post hoc model evidence was computed with Bayes factors (BF) and posterior probabilities of association (PPA) to account
for multiple testing. General cognitive functioning, verbal intelligence, verbal memory,
working memory, and motor speed were lower in the CUD group compared with nonusers (p < .011; 1.9 < BF < 3,217). CUD was associated with altered functional connec-
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tivity in a network comprising the motor-hand region in the superior parietal gyri and the
anterior insula (p < .04). These differences were not explained by alcohol, other drug use,
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or education. No associations with CUD were observed in cortical thickness, cortical surface area, subcortical or cerebellar volumes (0.12 < BF < 1.5), or graph-theoretical metrics
of resting state connectivity (PPA < 0.01). In a large sample collected irrespective of cannabis used to minimize recruitment bias, we confirm the literature on poorer cognitive
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functioning in CUD, and an absence of volumetric brain differences between CUD and
non-CUD. We did not find evidence for or against a disruption of structural connectivity,
whereas we did find localized resting state functional dysconnectivity in CUD. There was
sufficient proof, however, that organization of functional connectivity as determined via
graph metrics does not differ between CUD and non-user group.
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I N T RO DU CT I O N

whole brain approach. These studies report higher and lower functional connectivity in different regions, probably due to small sample

Views on cannabis use are changing in the United States. After legali-

sizes and different methodological approaches (Cheng et al., 2014;

zation of medical cannabis and more recent decriminalization/legaliza-

Filbey, Gohel, Prashad, & Biswal, 2018; Orr et al., 2013; Thijssen

tion of recreational use in many states, it is likely that more people

et al., 2017).

will use cannabis (Pearlson, 2020). Despite a recent meta-analysis

While inconsistencies in the literature could reflect a number of

reporting no link between legalization of medical cannabis and

methodological differences, three issues appear to be limiting our

increased use (Sarvet et al., 2018), cannabis use and cannabis use dis-

understanding of the relationship between cannabis use and brain

order (CUD) are increasing (Compton, Han, Jones, Blanco, &

structure and function. First, many studies use small sample sizes with

Hughes, 2016; Hasin et al., 2017; Wang, Davies, Halmo, Sass, &

limited statistical power, which reduces the chance of detecting a true

Mistry, 2018), whereas the perceived risk of cannabis use is decreas-

effect and decreases the likelihood that a statistically significant result

ing (Compton et al., 2016; Wen, Hockenberry, & Druss, 2019). A criti-

reflects a true effect (Button et al., 2013). Second, the definition of

cal issue is that the evidence base regarding the safety of cannabis

cannabis use varies dramatically between studies, potentially limiting

use is incomplete. Specifically, more information is needed regarding

generalizability. Third, ascertainment strategies can result in subtle

potential risks of long-term cannabis use, particularly on brain

biases that can skew results, particularly for case–control studies

function.

where cases and controls are drawn from different populations

The importance of examining the effect of cannabis on brain phe-

(Delgado-Rodriguez & Llorca, 2004; Kopec & Esdaile, 1990). To over-

notypes is underscored by evidence that chronic use is associated

come these limitations, we studied the association of CUD on cogni-

with lower global neuropsychological function and underperformance

tive and neuroimaging measures in a relatively large sample (n = 205)

in tasks of verbal learning and memory, attention, and psychomotor

of individuals recruited without regard to their cannabis use status

function (Broyd, van Hell, Beale, Yücel, & Solowij, 2016; Crane,

and used DSM criteria to define CUD. Additionally, the use of multi-

Schuster, Fusar-Poli, & Gonzalez, 2013; Scott et al., 2018). Although

modal imaging and detailed cognitive assessment enables the simulta-

this association may be bidirectional (Jackson et al., 2016; Meier

neous investigation of the effect of CUD on multiple brain and

et al., 2018) the cognitive effects of cannabis are particularly relevant

behavioral variables in the same individuals.

for adolescents and young adults (Volkow, Baler, Compton, &

We hypothesized that CUD would be associated with abnormal

Weiss, 2014). Furthermore, effects are more prominent within 72 hr

structural and functional connectivity involving brain regions that are

of last use with limited evidence that effects persist after longer

rich in cannabis receptors, including cerebellum, subcortical structures,

periods of abstinence (Scott, Slomiak, et al., 2018).

cingulate, and frontal areas (Burns et al., 2007; Glass, Faull, &

Initial findings on brain morphometry mostly report a decreased
hippocampal

and

amygdala

volume

(Lorenzetti,

Solowij,

&

Yücel, 2016; Murray et al., 2017; Rocchetti et al., 2013), but these

Dragunow, 1997). We also expected to replicate prior findings on
poorer cognitive function in verbal tasks and negative findings regarding the associations between cannabis use and brain morphometry.

have largely been superseded by recent large-scale studies that did
not identify cannabis effects on cortical thickness or subcortical volumes (Chye et al., 2019; Gillespie et al., 2018; Meier, Schriber,
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Beardslee, Hanson, & Pardini, 2019; J. M. Orr, Paschall, &
Banich, 2016; Scott et al., 2018; Thayer et al., 2017). Nevertheless, a

2.1

|

Participants

smaller hippocampal volume has been associated with current cannabis dependence (Chye et al., 2019), and tetrahydrocannabinol (THC, a

Participants (aged 18–70 years) were recruited via flyers, advertise-

psychoactive component of cannabis) positive urine but not lifetime

ments in local newspapers, and Craigslist as the control group of an

use (Owens, Sweet, & MacKillop, 2020). In contrast, white matter

ongoing study into psychosis (Mathias et al., 2017). To maintain gen-

integrity, as inferred from fractional anisotropy (FA) derived from dif-

eralizability, participants were allowed to have common psychiatric

fusion tensor imaging (DTI) may be reduced in cannabis users (Arnone

disorders (except for psychosis) and rates of psychiatric disorders in

et al., 2008; Becker, Collins, Lim, Muetzel, & Luciana, 2015; Epstein &

our sample reflect national averages in this population (Tables 1 and

Kumra, 2015; Gruber, Dahlgren, Sagar, Gönenç, & Lukas, 2014; Jaco-

S1a–d). All participants underwent formal diagnostic assessments

bus, Squeglia, Bava, & Tapert, 2013; Jakabek, Yücel, Lorenzetti, &

using the Structured Clinical interview for DSM-IV (First, Spitzer, Gib-

Solowij, 2016; Manza, Yuan, Shokri-Kojori, Tomasi, & Volkow, 2019;

bon, & Williams, 2002) (see Supporting Information). Exclusion criteria

Murray et al., 2017; J. M. Orr et al., 2016; Shollenbarger, Price,

included a history of major medical disorders, severe head injury, MRI

Wieser, & Lisdahl, 2015), even after months of abstinence (Ashtari,

contraindication, IQ < 70, dementia, traces of drugs other than THC in

Cervellione, Cottone, Ardekani, & Kumra, 2009). Although many stud-

urine, and drug intoxication during cognitive or MRI assessment.

ies have looked at functional connectivity and cannabis use, most

Participants were diagnosed with CUD (n = 57) if they (a) met

studies involve activation tasks and/or region of interest approach

DSM-IV criteria for current or partially remitted CUD (n = 7 for abuse,

(Blest-Hopley, Giampietro, & Bhattacharyya, 2018). Indeed, only a

n = 23 for current dependence, n = 11 for partial remission); or (b) met

handful of studies have looked at resting state connectivity using a

criteria for remitted CUD for >1 year but had positive THC urine test

3
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TABLE 1

Sample characteristics
N

Non-CUD

CUD

148

57

62 (41.9%)

28 (49.1%)

.432e

40 (18–70)

37 (19–69)

.182f

-

11 (1–40)

4 (2–8)

3 (2–6)

<.001a

17 (11.5%)

3 (5.3%)

.292b

No diagnosis

95 (64.19%)

-

Depression

14 (9.46%)

8 (14.04%)

.327e

PTSD

12 (8.11%)

4 (7.02%)

1.000e

Anxiety disorders

6 (4.05%)

5 (8.77%)

.184b

ADHD

0 (0%)

1 (1.75%)

.278e

Alcohol abuse/dependence

30 (20.27%)

21 (36.84%)

.019e

Drug other than CB abuse/dependence

15 (10.14%)

20 (35.09%)

.019e

3 (1.99%)

0 (0%)

.562e

6 (3.97%)

2 (3.51%)

1.000e

2 (1.32%)

0 (0%)

1.000e

2 (1.32%)

0 (0%)

1.000e

Nr drinks per month, mean (SD)

9 (19)

14 (17)

.001f

Currently smoking, n (%)

46 (31.08)

42 (73.68)

< .001e

FTND, median (range)b

0 (0–9)

3 (0–9)

< .001g

a

Male, n (%)
Age (range)
Duration of CB use, mean (range in years)
Education, median (range)

b

c

On social disability, n (%)

p

Axis I psychiatric diagnoses, n (%)

Medication, n (%)d
Anxiolytic
Antidepressant
Atypical antipsychotic

d

Anticonvulsantd
Alcohol and nicotine

Note: Diagnoses are lifetime diagnoses.
Abbreviations: CB, cannabis; FTND, Fagerström test for nicotine dependence (ranges from 0 to 12).
a
Wilcoxon rank sum test.
b
Fisher's exact test.
c
Ncognition = 142 + 53; Nanatomy = 107 + 45; NDTI = 110 + 42; Nresting_state = 92 + 39 non-CUD + CUD
respectively; see Table S1a–d.
d
missing data cannabis duration (n = 3); FTND (n = 36, equal percentage in the non-CUD and CUD
group),
e
ordinal: (1) Grade 6 or less; (2) Grade 7–12 without graduation; (3) high school/GED Graduate; (4) part
college; (5) 2-year college/trade school graduate; (6) 4-year college graduate; (7) part graduate school or
professional school; (8) complete graduate or professional school.
f
None of the participants used mood stabilizers or lithium. Atypical antipsychotic medication was used
for treatment of MDD; Anticonvulsant was used for nerve pain.
g
Welch's t test.

(n = 9) or mentioned they used socially (n = 6). Individuals who did not

boards at Hartford Hospital and Yale University. All participants pro-

use were defined as non-CUD (n = 148). Non-CUD participants were

vided written informed consent.

excluded if they tested positive for THC (n = 13) or mentioned that
they used occasionally (n = 18) or use was unknown (n = 1).
Figure S1 provides an overview of final sample size after quality

2.2
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Cognitive assessment

control for each modality. Since (supervised) abstinence of 3 to
28 days

normalizes

functional

connectivity

(Blanco-Hinojo

Under supervision, participants completed a cognitive test battery

et al., 2017; Jacobus et al., 2012), cannabinoid receptor density

(“Charlie,”

(D'Souza et al., 2016; Hirvonen et al., 2012), and cognitive perfor-

et al., 2017)), which included fully computerized and computer-aided

mance (Scott, Slomiak, et al., 2018), individuals in full remission were

administration of tests listed in Table 2. A composite score of general

https://github.com/sammosummo/Charlie,

(Mathias

classified as past-CUD and placed in a separate group. This group

intellectual functioning denoted by g was derived as the first PCA

was too small (n = 22) for analyses and was excluded from the cur-

component (see Supporting Information). Final group sizes were

rent study. The protocol was approved by institutional review

142 non-CUD, 53 CUD.

4
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TABLE 2

Included tests from cognitive tests battery

Domain

Test

Description

General cognitive ability

g

First component of principal component analyses using all cognitive
measures listed below.

Verbal intelligence

Wechsler test of adult Reading
WASI vocabulary

Subjects read aloud a list of 50 irregularly spelled words. Score is the
number of correctly pronounced words.
Subjects answer questions about the meaning of words (e.g., what does
winter mean?).

Abstract reasoning

WASI matrix

Subjects view an incomplete matrix and select the response that
completes the matrix.

Verbal and semantic fluency

COWAT: Controlled Oral word
association test

Subjects list as many words as possible in 60 s. In the first three trials,
the words must begin with the letters, F, A, and S (verbal fluency). In
the fourth trial, the words must be animals (semantic fluency).

Processing speed and
executive function

Trail making A and B

Computerized Trail making: Subjects click on circles presented on the
screen in a specified order. The order is either consecutive letters (A),
or alternating numbers and letters (B). Output is total time taken to
complete the trail.

Processing speed

Digit symbol

A key of digit symbol pairs is presented at the top of the screen and
subjects indicate whether a target digit symbol pair presented at the
center of the screen matches any pair from the key. Subjects
complete as many trials as possible in 90 s.

Verbal memory

CVLT: California verbal learning test

Subjects hear an audio recording of 16 words and repeat out loud as
many words as they can recall. This is repeated for five trials. Sum
correct is the total number of correct recalls over all five trails. On
the sixth trial (recall condition), subjects list as many words as they
can recall without first hearing the audio recording. In the
recognition condition, subjects recognize the 16 target words
presented alongside 32 non-target words.

Working memory

Span forward and backward
Letter number sequencing

Subjects hear sequences of letters or numbers that increase in length
throughout the trials and repeat these sequences out loud. In the
forward condition, subjects repeat the sequences in the order in
which they heard them. In the backward condition, subjects repeat
the sequences in reverse order.
Same as above, but the sequences contain both letters and numbers
and subjects repeat the letters in numerical order, followed by the
letters in alphabetical order.

Facial memory

Penn face memory test

Subjects see images of faces and are asked to try to remember them.
After they have seen all the faces, they perform a recognitionmemory task. Each trial comprises a face (either an old face or a new
one), and subjects make old/new judgments. Direct and delayed
correct responses were averaged.

Emotional memory

Penn emotion recognition test

Subjects see a color image of a face expressing an emotion (happy, sad,
fearful, and angry) or with a neutral expression. Subjects make their
responses by clicking on the words printed to the screen. There is no
feedback and there are no practice trials.

Spatial memory

Corsi SCAP: Spatial capacity
delayed response test

Subjects observe the sequence of blocks in which circles appear, and
then repeat the sequence back in order. The task starts with a small
number of blocks and gradually increases in length up to nine blocks.
Three different conditions (clicking the block where circles appeared
(order irrelevant), clicking in order (similar to the original Corsi),
clicking blocks in order where circles appeared, then click in order
the blocks were crosses appeared) were averaged to obtain one
score.
On each trial, the subject sees a study array comprising three to five
yellow circles in random positions on the screen. The study array is
removed and, after a delay, is replaced by a single green circle (the
probe). The subject indicates whether the probe has the same spatial
location as one of the original circles. In this version of the SCAP,
there are 14 three-, 14 four- and 14 five-item trials.

5
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TABLE 2

(Continued)

Domain

Test

Description

Sustained attention

IPCPTs: Identical pairs continuous
performance test

On each trial, the subject sees a three-item symbol array, and presses
the space bar each time the current array matches the array from the
previous trial (effectively a 1-back task). Trials have a duration of
1.5 s. There are 200 trials in the test phase.

Motor speed

Orientation test

Subject sees either a blue square (during the first 10 trials) or a blue
square and a red circle (during the last 10 trials) positioned randomly
on the screen. The task is to click on the blue square as quickly as
possible. After each trial the blue square becomes smaller and the
red square becomes larger. It is similar to the mouse practice task
from Gur et al., 2001. Output is total time taken to complete the
test.

2.3

|

Neuroimaging

FD > 0.5 mm were removed. Runs with >20% high motion time points
were discarded. Most subjects (67%) had all 4 runs (in both groups).

Imaging was conducted on a Siemens Skyra 3 T scanner at the Olin

Final group sizes were 92 non-CUD, 39 CUD. See Supporting Infor-

Neuropsychiatry Research Center, Institute of Living, Hartford Hospi-

mation for details on preprocessing.

tal. Sequences were modeled on the Human Connectome Project

The cortex was parcellated according to the Gordon atlas

(HCP) imaging protocols (Glasser et al., 2016; Smith et al., 2013;

(Gordon et al., 2016), subcortical regions were segmented with the

Sotiropoulos et al., 2013). Anatomical scans were acquired with a

Harvard-Oxford atlas (Desikan et al., 2006), and cerebellum with FSL's

T1-weighted gradient echo pulse sequence with the following param-

probabilistic

eters: voxel size = 0.8 mm isotropic; TE/TR/TI = 2.09/2400/1010 ms;

Ramnani, 2009). Total number of brain parcels was 382. Global signal

flip angle = 8 ; duration = 7:02 min. DTI scans with 90 directions and

regression was applied (based on all voxels) and pair-wise correlations

b-values of 0 and 2000 s/mm2 (voxel size = 1.8 mm isotropic;

between all 382 regions were Fisher r-to-z transformed. The correla-

TE/TR = 92.80/4250 ms; duration = 6:50 m) were acquired in 4 scans:

tion matrix was checked for outliers. First, edge-wise outliers (>4 SD)

two left-to-right and two right-to-left phase encoding direction.

were detected. Second, for each subject the number of outlier-edges

Resting-state data included four 5:08 min scans (two left-to-right and

was calculated. Based on the histogram of the number of outlier-

two right-to-left phase encoding direction) where participants were

edges per subject, five subjects (two CUD, three non-CUD) where

asked to keep their eyes open and let their minds wander freely.

defined as outliers (>1,000 outlier-edges). These subjects did not devi-



atlas

(Diedrichsen,

Balsters,

Flavell,

Cussans,

&

Acquisition parameters were: TE/TR = 36/720 ms; flip angle = 52 ;

ate in their mean connectivity. Analyses were repeated without these

voxel size = 2.1 mm isotropic.

subjects.

T1-weighted images were analyzed with Freesurfer version 5.3
(Fischl, 2012) to obtain cortical thickness and surface area measurements for 68 cortical and volumetric measures for 14 subcortical

2.4

|

Organization of functional connectivity

regions and the cerebellum of the Desikan-Killiany parcellation
(Desikan et al., 2006). Image quality was assessed via MRIQC

The organizational structure of resting-state functional connectivity

(Esteban et al., 2017), excluding scans with MRIQC score ≥ 0.5. Final

(FC) was assessed with two complementary approaches: network-

group sizes were 107 non-CUD, 45 CUD.

based static (NBS) and graph-theoretical metrics.

Diffusion images were processed using FMRIB's Software Library

NBS (Zalesky, Fornito, & Bullmore, 2010) is a nonparametric

(FSL) (Smith et al., 2004) version 10. Preprocessing included brain

method that exploits the extent to which connections comprising the

extraction, correction for motion and eddy current distortions, and

contrast of interest (determined with an F-test to allow for two-sided

tensor fitting resulting in individual FA maps. FA maps were fed into

effects) are interconnected. The size of the connected component is

Tract-Based Spatial Statistics (TBSS) (Smith et al., 2006). Average FA

based on the number of connections (extent) or sum of the F-statistics

was calculated for the whole skeleton and 20 white matter tracts

of all edges (intensity).

based on the John's Hopkins University white matter atlas (Hua

Graph-theoretical metrics were estimated using the Brain Con-

et al., 2008). Two motion estimates calculated during the DTI distor-

nectivity Toolbox (BCT, www.brain-connectivity-toolbox.net). We

tion correction were used as covariates. Final group sizes were

focused on metrics of (a) global connectivity (global efficiency);

110 non-CUD, 42 CUD.

(b) regional connectivity (degree, strength, and clustering coefficient);

Preprocessing of resting-state data was based on HCP pipelines

and (c) modular organization (participation coefficient, modularity).

(Glasser et al., 2013). Framewise displacement (FD) and root-mean-

Because graph metrics are sensitive to the density of the graph

square change in blood-oxygen-level-dependent (BOLD) signal from

(i.e., the fraction of present connections to all possible connections),

volume to volume (DVARS) was calculated and timepoints with

we selected the same number of edges for each participant, namely

6
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the top 1 to 40% (increments of 1%) of the strongest positive or nega-

use disorder other than cannabis or nicotine (SUD), and years of edu-

tive edges. This upper bound was based on the density of positive

cation approximated as an ordinal variable (see Supporting Informa-

versus negative edges in each participant, thus ensuring that the top

tion), and social disability status as a proxy for social economic status

40% of positive edges included the same number of positive only

(although this did not differ between groups, p = .292). Because corre-

edges for each participant (and likewise for top 40% negative edges).

lations between nicotine use and brain structure (Liao, Tang, Liu,

Graphs based on positive and negative correlations were analyzed

Chen, & Hao, 2012) and function (Filbey et al., 2018) have been

separately for global efficiency, clustering coefficient, and strength.

reported, we also regressed out the effects of nicotine dependence

Modularity and participation coefficient were computed on the union

(Fagerström test) for any significant brain metrics.

of positive- and negative-correlation based graphs (thus, graph density
for these was twice that of other metrics). A Louvain approach with
negative asymmetry was used to estimate modularity (Rubinov &

3
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Sporns, 2011).
Graph-theoretical metrics were computed for each density

3.1

Cognition

|

threshold (1–40%), thus forming a curve as a function of density. The
difference between the groups was computed as the area between

Seven tests showed FDR-corrected group differences in the domains of

their respective curves. Permutations (n = 50,000) of group member-

general cognitive ability, verbal intelligence, verbal memory, working

ship were used to assess significance. When regional output was cre-

memory and motor speed (Cohen's d = −0.39 to −0.80, p = <.011,

ated (clustering coefficient, strength, degree, participation coefficient),

BF > =1.9, Figure 1, Table 3). As cognitive test-scores are often corre-

p-values were corrected for multiple testing (382 regions) with an

lated (Figure S2), we performed a multiple regression analysis including

FDR-correction. Effect sizes and Bayes factors were computed over

each of the test scores (excluding g; variance inflation factors <2.67), to

the mean over all densities.

determine if a single measure was differentially associated with CUD
status. Only the total sum of correctly recalled words significantly differed between the CUD and non-CUD group (p = .0006) in this analysis.

2.5

|

Statistical analyses

Covariates common to all analyses were age, age2, sex, and their inter-

3.2

Brain morphometry

|

actions. Cognitive, morphometry, and DTI data were visually checked
for normality (density and Q-Q plots) and transformed if necessary

No statistically significant neuroanatomical differences were observed

(only for cognitive data, with either datae; data−1; log[data], depending

in subcortical volumes, cerebellar volume, cortical thickness or cortical

on the distribution). In the structural data, outliers (>4 SD) were

surface-area (Cohen's d = −0.40 to 0.37; p > .026 uncorrected,

removed as they likely reflect segmentation errors. Differences

BF < 1.5; Figure 1, Tables S2 and S3). BF was <0.3 for the majority of

between groups were assessed via t tests, and multiple regression

the regions, including many frontal and subcortical regions, providing

(glm function) in R (R Core Team, 2017). The threshold for statistical

support for the null hypothesis (Jeffreys, 1961). Although findings

significance was set at p < .05 after FDR correction. Bayes factors

were inconclusive (0.3 < BF < 1.5) for 22 regions, these regions did

(BF) (Jarosz & Wiley, 2014; Jeffreys, 1961) were computed on

not differ between the groups when correcting for the number of

imputed data with BayesFactor package in R (Morey & Rouder, 2018)

tests (PPA < 0.14 when BF < 1.5 and prior probability <0.1).

against a null-interval of (−0.1, 0.1) (Morey & Rouder, 2011). BF > 3 is
considered substantial, BF > 10 is strong evidence for the alternative,
and BF < 0.3 is substantial evidence for the null (Jeffreys, 1961).

3.3

Diffusion imaging

|

Bayes Factors with intermediate values (i.e., greater than 0.3 but less
than 3) neither confirm nor reject a specific hypothesis. Rather, such

Mean FA of several bundles was lower the CUD group (Cohen's d <

factors are considered inconclusive, without enough evidence to

−0.41, p < .05 uncorrected; Figure 1; Table S4). However, none were

definitively determine the presence or absence of an effect. The pos-

statistically significant after FDR correction. BFs ranged from

terior probability of association (PPA) was used to interpret BF with

1.07–2.19, indicating inconclusive evidence for a group difference in

multiple testing (Stephens & Balding, 2009) and can be interpreted as

FA of these bundles.

PPA < 0.25 for substantial evidence and PPA < 0.10 for strong evidence for the null hypothesis (see Supporting Information).
Post hoc analyses examined the relationship of (log-transformed)

3.4

Resting-state connectivity

|

duration of cannabis use and age of onset of cannabis use on measures that significantly differed between groups. We tested for the

3.4.1

|

Network-based statistics

influence of confounding variables by regressing out (in separate analyses) the effects of number of alcoholic drinks/month, lifetime diag-

Significant components based on intensity were found after

nosis of alcohol use disorder (AUD), lifetime diagnosis of substance

thresholding for group differences at F ≥ 15, 16 and 17 (p = .034,

7
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F I G U R E 1 Overview of all effect sizes for all
modalities examined in this study; each dot
represents one test or region. Negative effect
sizes mean variable of interest is “lower” in CUD
group. Effect sizes of modularity and positive/
negative efficiency were − 0.02, 0.29, 0.15,
respectively

Effect sizes of cognition and brain structure
1.0

Cohen's d

0.5

0.0

−0.5

−1.0
Cognition

Surface Area

Thickness

Subcortical volume

FA

Modality

Effect sizes of resting state metrics
1.0

Cohen's d

0.5

0.0

−0.5

−1.0
Degree
(pos)

Degree
(neg)

Strength
(pos)

Strength
(neg)

Clustering
(pos)

Clustering ParticipationParticipation All edges
(neg)
(pos)
(neg)

Metric

.023, and .018, respectively). The intensity-component at F ≥ 15

3.4.2

|

Graph-theoretical metrics

included 5 edges connecting 6 nodes: the bilateral motor-hand area in
the superior parietal gyrus (SPG), bilateral insula, right fusiform gyrus,

There were no group differences in global or regional metrics. There

and the right inferior temporal gyrus. In CUD, FC was lower between

were no group differences in mean FC between resting state modules;

SPG and insular regions; but higher between the right insula and fusi-

mean FC strength within module or mean FC strength between each

form gyrus, and between the fusiform gyrus and the inferior temporal

module and all other modules; or mean FC over the entire matrix. See

gyrus (Figures 2 and S3, Table 4). Based on extent, one component

Figure 1 for effect sizes, Table S5 for an overview of marginal findings

was found at F ≥ 15 (p = .030) comprising 9 edges over 10 mostly

at p < .005 uncorrected. Although BF > 6, PPA < 0.01 indicates strong

occipital nodes. FC between the bilateral middle occipital gyrus and

evidence that none of the metrics differed between the groups.

nodes of the visual network was higher in CUD, whereas FC between
the left precuneus and the bilateral lingual gyrus was lower (Figures 2
and S3, Table 4).

3.4.3

|

Global signal regression

Of the entire FC matrix, three edges reached FDR-corrected significance. One edge overlapped with the NBS-intensity component

To test for bias related to the global signal, we reran the FC analyses

(right SPG to right insula; Table 4, Figure S4). This was also the only

on data without global signal regression (GSR). There were no group

edge that had sufficient evidence for a group difference (PPA > 0.95).

differences in the NBS approach. Preparing the data for the graph

8

KOENIS ET AL.

TABLE 3

Means (SD) of cognitive tests for subjects with and without cannabis use disorder (CUD)

Domain

Test

Non-CUD

CUD

Cohen's d

p

BF

General cognitive ability

g

0.12 (1.03)

−0.31 (0.83)

−0.44

.003

Verbal and semantic fluency

COWAT, animal

0.02 (1.00)

−0.06 (1.01)

−0.09

.591

0.13

COWAT, F-A-S

0.04 (1.00)

−0.10 (1.00)

−0.14

.404

0.17

Verbal intelligence

WTAR

0.15 (1.05)

−0.42 (0.71)

−0.59

<.0001

37.91

Vocabulary

0.14 (1.04)

−0.36 (0.78)

−0.51

.0004

11.72

Verbal memory

CVLT, sum correct

0.20 (0.98)

−0.55 (0.83)

−0.80

<.0001b

3,216.71

CVLT, recall

0.11 (0.99)

−0.31 (0.97)

−0.43

.009

CVLT, recognition

−0.02 (1.08)

0.05 (0.74)

0.07

.616

0.12

Corsi

0.06 (0.99)

−0.16 (1.02)

−0.22

.216

0.30

SCAP

0.03 (1.00)

−0.08 (1.00)

−0.11

.481

0.15

Emotion recognition

0.00 (0.94)

−0.01 (1.17)

−0.02

.920

0.11

Spatial memory

Emotional memory

a

a

3.71

3.26

Facial memory

Face memory

0.02 (1.03)

−0.06 (0.93)

−0.08

.615

0.12

Working memory

Forward

0.05 (0.99)

−0.15 (1.02)

−0.20

.226

0.27

Backward

0.08 (1.02)

−0.21 (0.94)

−0.29

.069

0.61

Letter-number

0.10 (1.03)

−0.28 (0.87)

−0.39

.011a

1.89

Sustained attention

IPCPTs

0.05 (1.00)

−0.14 (0.99)

−0.19

.251

0.25

Abstract reasoning

Matrix reasoning

0.07 (1.05)

−0.18 (0.82)

−0.24

.095

0.39

Motor speed

Orientation time

0.12 (1.01)

−0.32 (0.91)

−0.44

.005

Processing speed

Digit symbol coding

0.05 (0.99)

−0.13 (1.02)

−0.17

.296

0.22

Processing speed & executive function

Trail making A

−0.02 (1.02)

0.06 (0.96)

0.08

.627

0.12

Trail making B

−0.05 (0.99)

0.12 (1.01)

0.17

.301

0.22

a

3.67

Note: Values are standardized residuals. Bold indicates significant at p < .05, FDR corrected.
Abbreviations: BF, Bayes factor; COWAT, controlled oral word association test; CVLT, California verbal learning test; IPCPT, identical pairs continuous
performance test; SCAP, spatial capacity delayed response test; WTAR, Wechsler adult reading test.
a
Significant at p < .05 (uncorrected) after controlling for lifetime substance abuse/dependence other than cannabis. The other tasks remain significant at
p < .05 FDR corrected.
b
Significant at p < .05 (FDR corrected) after controlling for education. The other tasks are no longer significant.

F I G U R E 2 Affected network in CUD at F ≥ 15, based on intensity (a) and extent (b). Red/thick edge, stronger functional connectivity in CUD;
Blue/thin edge, weaker functional connectivity in CUD. SM, somatomotor cortex; Attn, attention

metrics, it was noticed that the CUD-group had stronger mean FC

against a group difference in within network FC (p < .032, BF < 1.42,

over the entire matrix (p = .0363, Cohen's d = 0.40), though evidence

PPA < 0.41) nor mean outward FC of each network (p < .0091,

was inconclusive (BF = 1.3). For the GSR processed matrix there was

BF < 3.74, PPA < 0.65). See Supporting Information for details.

evidence for the absence of a group difference in mean FC (p = .297,

Percentage of positive and negative edges was more variable in

BF = 0.26). Group differences of FC between each of the resting state

the non-GSR data; in order to set the number of edges equal across

modules (120 combinations) did not reach FDR corrected significance

all participants, positive graph metrics were computed at 1–25% den-

(p > .0024, BF < 13.5, PPA <0.66). There was no evidence for or

sity, and negative metrics at 1–13% density (as opposed to 40% for
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TABLE 4

Mean (SD) functional connectivity and effect sizes of edges in the NBS component (intensity, F ≥ 15) and FDR significant edges
BFa

Non-CUD

CUD

Cohen's d

p

−0.020 (0.082)

0.046 (0.099)

0.750

.00059cdefgh

R sup parietal to L insula

0.023 (0.094)

−0.043 (0.048)

−0.793

.00000

R fusiform R to R insula

−0.015 (0.074)

0.043 (0.088)

0.750

.00053cdefg

NBS—intensity
R fusiform to R Inf temporal

cdg

106
214
107

0.022 (0.068)

−0.051 (0.066)

−1.078

.00000

0.021 (0.082)

−0.051 (0.088)

−0.863

.00004cg

728

−0.022 (0.084)

0.048 (0.115)

0.747

.00104cdefghi

101

L precuneus to L lingual

0.015 (0.096)

−0.060 (0.102)

L mid occipital to R mid temporal

−0.035 (0.128)

0.087 (0.175)

L mid occipital to R fusiform

−0.039 (0.132)

R mid occipital to R fusiform

−0.041 (0.152)

0.092 (0.218)

L mid occipital to R cuneus

−0.028 (0.107)

0.065 (0.135)

L mid occipital to R lingual

−0.026 (0.089)

L precuneus to R lingual

0.017 (0.089)

L mid occipital to cuneus

−0.027 (0.100)

0.059 (0.126)

0.786

.00040

L accumbens to R hippocampus

−0.019 (0.068)

0.037 (0.072)

0.822

.00008cg

351

L mid frontal to vermis crus I

0.019 (0.070)

−0.041 (0.075)

−0.837

.00006f

457

R sup parietal to R insulab

0.022 (0.068)

−0.051 (0.066)

−1.078

.00000g

180,522

R sup parietal to R insula

b

L sup parietal to R insula

cg

180,522

NBS—extent
L mid occipital to L lingual

−0.756

.00025

cdfghi

117

0.851

.00023cdfghi

584

0.801

.00053

cdfghi

244

0.763

.00105

cdfghi

132

0.798

.00034cdfghi

235

0.055 (0.138)

0.767

.00132

cdfghi

141

−0.051 (0.098)

−0.745

.00039cdfghi

0.080 (0.183)

cdfghi

99
191

FDR

Note: Values are standardized residuals.
Abbreviations: BF = Bayes factor.
a
See Supporting information on interpretation of BF and multiple testing.
b
This edge is present in the FDR and NBS-intensity network.
c
Not significant after controlling for nicotine dependence.
d
Not significant after controlling for drinks/month.
e
Not significant after controlling for SUD.
f
Not significant after controlling for education.
g
Not significant when excluding outliers.
h
Not significant after controlling for DVARS.
i
Not significant after controlling for lifetime AUD.

both positive and negative metrics in the main GSR analyses). There

3.5.2

|

Cross modality correlations

were several group differences at p < .005 uncorrected (Table S6).
However, as in the GSR analyses, none of the findings survived FDR

Cognitive and neuroimaging measures found to differ between the

correction and PPA suggested an absence of a group difference

CUD and non-CUD group were correlated to examine potential com-

(PPA < 0.20 for 24 of 28 variables, the remaining 4 were inconclusive

mon effects across cognitive and brain measures. None of these cor-

PPA < 0.33). Findings did not overlap with results done on GSR data

relations survived FDR correction and BFs were inconclusive at best

with the same density range (Table S7).

(BF < 9.8, PPA < 0.15; see Supporting Information).

3.5

3.5.3

3.5.1

Post hoc analyses

|
|

Duration of use

|

Confounding variables

Analyses showing significant results were repeated after regressing
out the effects of confounding variables to determine if results were

Significant results mentioned above were tested for correlation with

influenced by comorbidity.

duration of cannabis use and age of first cannabis use (in CUD group

Group differences in cognition remained significant after

only). None of the cognitive or resting state variables correlated with

adjusting for alcoholic drinks/month and AUD, but four tests did not

these metrics, although evidence is inconclusive (0.2 < BF <1.8; see

reach FDR significance after covarying for SUD (Table 3). When cor-

Supporting Information).

recting for education, only verbal learning reached (FDR-corrected)
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significance. Correcting for social disability status did not change the

The absence of significant morphometric differences associated
with CUD is consistent with previous large studies on recreational

results.
The NBS-intensity components were roughly the same when

cannabis use (Orr et al., 2016; Scott, Rosen, et al., 2018; Thayer

alcoholic drinks/month, AUD, SUD, education, social disability, or

et al., 2017), with similar effect sizes (Scott, Rosen, et al., 2018;

DVARS were added as covariates. The connections between the SPG

Weiland et al., 2015). Our findings add to the literature that morpho-

and right insula were the most stable. The NBS-intensity component

metric differences are absent even when individuals who meet CUD

did not reach significance when corrected for nicotine dependence,

diagnostic criteria are compared with non-users from the same popu-

and showed a different network when excluding five outliers. The

lation. However, a few recent large studies did find morphometric dif-

NBS-extent component remained significant only after correction for

ferences in association with cannabis use. Chye, Lorenzetti,

SUD and social disability. Edges found at FDR significance were stable

et al. (2019); Chye, Suo, et al., 2019) found smaller hippocampi in

after controlling for above mentioned confounding variables. See

CUD compared with controls and compared with nondependent

Table 4.

users, but not in nondependent users compared with controls. Owens
et al. (2020) found smaller hippocampi in THC+ participants, but not
in participants with lifetime CUD, whereas Manza et al. (2019) found

4

|

DISCUSSION

lower cortical thickness and gray matter density in the precuneus in
lifetime CUD compared with carefully matched controls. These differ-

We investigated the association between CUD and measures of cog-

ences in results and sample characteristics suggest that different phe-

nition, brain structure, and brain function in a large sample selected

notypes (e.g., THC+, current vs. lifetime CUD, frequency of usage,

without regard to cannabis use status. Consistent with prior studies,

etc.) may have different associations with brain morphometry. In addi-

CUD individuals showed poorer performance on measures of verbal

tion, it emphasizes the need for replication studies.

intelligence, verbal memory, working memory, and motor speed. We

Although the literature is consistent in reporting lower structural

did not find conclusive evidence for lower FA in the CUD group.

connectivity in participants with CUD (Arnone et al., 2008; Ashtari

Functional connectivity (FC) was altered in a component that included

et al., 2009; Becker et al., 2015; Epstein & Kumra, 2015;

lower FC between the bilateral superior parietal gyrus (SPG) and right

Gruber et al., 2014; Jacobus et al., 2009; Jakabek et al., 2016; Manza

insula. In contrast, there was substantial evidence that neither neuro-

et al., 2019; Murray et al., 2017; Orr et al., 2016; Shollenbarger

anatomical measures nor did graph-theoretical metrics of FC differed

et al., 2015; Zalesky et al., 2012), we did not find conclusive evidence

between groups. Results were not related to alcohol drinking behav-

for lower FA in the CUD group (0.3 < BF < 3). Functional connectivity

ior, AUD, or SUD, although nicotine dependence explained a portion

studies, however, are more inconsistent. Studies using a whole brain

of the variance in FC.

approach to investigate CUD-related resting state FC (Cheng

Apart from acute effects (Ranganathan et al., 2017; Schuster

et al., 2014; Filbey et al., 2018; C. Orr et al., 2013; Thijssen

et al., 2018), the causal link between cannabis use and educational

et al., 2017) have reported that cannabis users have: higher fractional

attainment (Defoe, Khurana, Betancourt, Hurt, & Romer, 2018;

amplitude of low-frequency fluctuations in right superior frontal

Lynskey & Hall, 2000), or cognition is unclear (Morin et al., 2019;

gyrus, SPG, semilunar node of the cerebellum, and weaker inter-

Scott, Slomiak, et al., 2018). A study on a cannabinoid receptor

hemispheric connectivity in the medial frontal cortex and pyramid of

1 (CB1) antagonist suggests that altered CB1-signaling is involved in

the cerebellum (C. Orr et al., 2013); stronger connectivity between

acute

(Englund

frontal and precentral gyri, and between frontal and cingulate gyri

et al., 2016). Frequent cannabis use is associated with a down-

(Cheng et al., 2014); weaker connectivity in the salience network and

regulation of these receptors, but receptor density returns to base-

posterior cingulate gyrus (Filbey et al., 2018). The largest study

line after abstinence (D'Souza et al., 2016; Hirvonen et al., 2012).

(130 CUD, 47 controls) found no cannabis-use associated differences

Similarly, cognitive impairments (Scott, Slomiak, et al., 2018; Tait,

in intra-network connectivity but did report a negative association

Mackinnon,

(Blanco-Hinojo

between duration of cannabis use and connectivity of the executive

et al., 2017) are recovered after abstinence, suggesting a causative

control network with the auditory and a sensorimotor network in can-

role. However, longitudinal twin studies show that individuals at risk

nabis users (Thijssen et al., 2017). We did not find differences in inter-

for substance abuse could have cognitive vulnerabilities before onset

network connectivity of data processed with global signal regression

of cannabis use (Jackson et al., 2016; Meier et al., 2018; Ross

(GSR); in non-GSR data there could be (evidence was inconclusive)

et al., 2019), although there is also evidence from a longitudinal

stronger inter-network FC between the cingulo-parietal (CP) and audi-

study for cognitive effects after persistent use (Meier et al., 2012).

tory network, and between the CP and somato-motor network in

When correcting for education, many of the cognitive and FA differ-

CUD. These inconsistent results, emphasized by the difference

ences between CUD and non-CUD disappeared, except for verbal

between results with and without GSR, illustrate the need for more

memory and FC. Verbal memory is one of the most robustly found

standardized methodological approaches and resist drawing general-

domains to be affected in relation to cannabis use (Broyd

ized conclusions.

THC-induced

&

verbal

Christensen,

memory

2011)

impairment

and

FC

et al., 2016; Crane et al., 2013). Possibly, these metrics may be associated with CUD through a different pathway.

We report weaker FC between bilateral motor-hand regions in
the SPG and the bilateral insula in the NBS-intensity and FDR
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approach, even after correcting for several confounders. In contrast,

bioavailability, long-term changes, or premorbid vulnerability to CUD.

the NBS-extent finding of stronger FC between nodes in the occipital

However, a standardized DSM diagnosis can be seen as a more reli-

cortex reached only marginal significance and did not survive correc-

able phenotype than (long-term) frequency of use or cumulative life-

tion for confounding variables. Although without GSR there were no

time use (Prince et al., 2018). It is also important to realize that CUD

group differences in NBS networks, the global signal (as inferred from

captures those people who not just use, but where use leads to prob-

mean FC over the entire matrix) was higher in the CUD group. Our

lems, which is potentially a different phenotype regardless of amount

results suggest that after removal of this signal, the CUD group still

of use. Third, results of the resting state analysis could be specific to

had different FC between specific regions. It should be stressed that

the parcellation atlas, as low resolution parcellations can lead to

the multiple comparison correction of NBS is at the component-level

unstable estimations. However, individual differences in graph metrics

rather than the edge-level, meaning that the null hypothesis is not

were largely conserved in parcellations with more than 250 regions

rejected for any specific edge, only for the component as a whole.

(Fornito, Zalesky, & Bullmore, 2010), suggesting our findings on a

The edges between the right SPG and right insula which reach FDR

333-region cortical parcellation should be stable. Fourth, although our

significance are not subject to this limitation. However, these findings

participants were not acutely intoxicated, cognitive functioning and

were attenuated when controlling for nicotine dependence. A study

structural/functional connectivity might improve after complete ces-

on nicotine addiction reported that weaker FC between the insula

sation of cannabis use for an extended period of time (Blanco-Hinojo

(seed region) and pre- and postcentral gyri was related to higher

et al., 2017; D'Souza et al., 2016; Hirvonen et al., 2012; Scott,

chances

&

Slomiak, et al., 2018; Tait et al., 2011). Yet, the required duration of

McClernon, 2015). Although it is likely that these connections are not

abstinence may depend on the frequency and intensity of use. THC is

unique to nicotine addiction but substance abuse related (c.f. the

extremely fat-soluble and can remain in fatty tissues (including brain)

involvement of the insula in drug craving [Naqvi, Gaznick, Tranel, &

for extensive periods of time (many weeks), especially after chronic

Bechara, 2014]), our results might be influenced by the higher preva-

use. Last, our sample comprised African Americans, which could limit

lence of nicotine smokers in the CUD group. Taking that into account

the generalizability of our findings. However, African Americans are

in combination with the marginal significance, our FC results should

an underrepresented group in psychiatry research while having a

be treated with caution and replication is needed.

higher prevalence of CUD than Caucasians (Wu, Zhu, & Swartz, 2016)

of

relapse

(Addicott,

Sweitzer,

Froeliger,

Rose,

We did not find conclusive evidence for the presence or absence

and we mostly confirm earlier findings.

of a correlation between age of onset and duration of use and cogni-

In conclusion, in a large sample that was collected irrespective of

tion or FC. The literature is also inconclusive on this association as

cannabis use to minimize recruitment bias, we confirm the literature

some studies report that earlier onset and longer use have a more det-

on poorer cognitive functioning in CUD, and an absence of volumetric

rimental effect on cognition and the brain, whereas other studies

brain differences between CUD and non-CUD. We did not find evi-

report an absence of such association. For a comprehensive overview

dence for or against a disruption of structural connectivity. We find

we refer the reader to (Nader & Sanchez, 2018). Discrepancies in the

disrupted FC in specific regions, although there was sufficient proof

literature could be due to the definition of “cannabis users,” the fidel-

that organization of FC as determined via graph metrics does not dif-

ity of self-report (Prince, Conner, & Pearson, 2018), or that early-

fer between CUD and non-user group.

onset users may have a higher intensity and frequency of use compared with late-onset users (Gruber, Sagar, Dahlgren, Racine, &
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